PMID: 2496332May 1, 1989Paper

Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits

Neurology
P D LydenG A Press

Abstract

Tissue plasminogen activator (tPA) dissolves intravascular thrombus and restores blood flow after thromboembolic vascular occlusion. The utility of this agent for treatment of stroke in humans may be limited by post-reperfusion hemorrhagic complications. We studied tPA-mediated thrombolysis in an animal model of cerebrovascular occlusion in order to determine what factors, if any, predispose tPA-treated animals to suffer hemorrhage. Small blood clot emboli were injected into the internal carotid arteries of rabbits. Angiograms confirmed occlusion of the middle cerebral artery or internal carotid artery in 100% of subjects. tPA or saline was administered as a 30-minute infusion at various times after embolization. Hemorrhage rates were similar in all groups regardless of treatment. tPA increased the prothrombin time and the thrombin time but not the partial thromboplastin time. There was no correlation between these changes in blood coagulation and the finding of cerebral hemorrhage. We observed a significant association between stroke severity and cerebral hemorrhage. We conclude that tPA treatment successfully causes thrombolysis of cerebral emboli without causing an increase in the incidence of cerebral hemorrhage in rabbits.

Citations

Jul 1, 1992·Annals of Neurology·G J del ZoppoO Busse
Apr 29, 2010·Current Neurology and Neuroscience Reports·Andrew Stemer, Patrick Lyden
Feb 1, 1992·Annals of Emergency Medicine·G M de Courten-MyersR E Myers
Apr 1, 1997·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·M A YenariG K Steinberg
Jan 1, 1995·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·G Boysen, UNKNOWN ECASS Study Group
Feb 27, 2001·Postgraduate Medical Journal·A C PereiraE A Warburton
Sep 19, 2007·Expert Opinion on Emerging Drugs·Paul A Lapchak, Dalia M Araujo
Feb 25, 2015·Experimental Neurology·Paul A LapchakPaul D Boitano
Apr 20, 2004·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Shailendra JoshiRoger Hartl
Mar 1, 2007·Journal of Vascular and Interventional Radiology : JVIR·Benjamin C CulpWilliam C Culp
Jan 1, 1992·Progress in Cardiovascular Diseases·S R Levine, T G Brott
May 1, 1992·The Journal of Emergency Medicine·K D Hoang, P Rosen
Apr 1, 1997·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·P D Lyden
Aug 19, 2008·International Journal of Stroke : Official Journal of the International Stroke Society·Samuel Yip, Justin Zivin
May 1, 1994·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·K OvergaardG Boysen
Feb 1, 1994·Stroke; a Journal of Cerebral Circulation·J S LeeJ M Zabramski
Jul 1, 1990·Stroke; a Journal of Cerebral Circulation·J A Zivin, J C Grotta
Nov 22, 1997·Stroke; a Journal of Cerebral Circulation·T F ChoudhriD J Pinsky
Apr 1, 1990·Stroke; a Journal of Cerebral Circulation·G J del ZoppoJ A Koziol
Mar 10, 2001·Stroke; a Journal of Cerebral Circulation·D F ChapmanJ Zivin
Dec 1, 1990·Stroke; a Journal of Cerebral Circulation·M M BednarC E Gross
Jan 1, 1992·Stroke; a Journal of Cerebral Circulation·Y OkadaM Fujishima
Jul 1, 1991·Stroke; a Journal of Cerebral Circulation·W M ClarkJ A Zivin
Aug 1, 1992·Stroke; a Journal of Cerebral Circulation·K OvergaardN H Diemer
Jun 1, 1992·Stroke; a Journal of Cerebral Circulation·L P CarterO Temeltas
Jan 31, 2007·Stroke; a Journal of Cerebral Circulation·Justin A Zivin
Jul 23, 2019·Stroke; a Journal of Cerebral Circulation·Patrick D Lyden
Mar 1, 1993·Journal of Cataract and Refractive Surgery·G R LesserR J Cionni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.